Many people living with SIBO experience difficulty with getting a diagnosis. That's because the symptoms of SIBO closely ...

IBS has classically been regarded as a “diagnosis of exclusion,” but new research suggested that might be changing with better diagnostic and treatment approaches.

SIBO is a condition that results from an overgrowth in bacteria in the small intestine and gut. Here, MDs explain SIBO causes ...

Qiagen NV added to its growing roster of panels cleared by the U.S. FDA in 2024 with the agency’s nod for its Qiastat-Dx Meningitis/Encephalitis assay. The clearance validates Qiagen’s strategy of ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has ...

The condition was originally identified as the reason why some people who’d had GI surgery or a digestive disease developed ...

James Van Der Beek is feeling optimistic after being diagnosed with cancer. The Dawson's Creek alum, 47, revealed the health ...

These effects are mediated via two G-protein-coupled receptors, cannabinoid receptor (CB) 1 and CB 2, which are widely expressed in the GI tract. The endocannabinoids anandamide and 2 ...

Gut health isn't the most glamorous of topics, but as many as 1 in 10 people regularly suffer from gastric symptoms like ...

Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device, ...

New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many ...

QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of ...